Seshu Tyagarajan, Chief Technology Officer at Candel Therapeutics, Inc. (CADL), sold 62,556 shares at $8.82 ($552K) on 2025-03-17, disclosed to the SEC on 2025-03-20.
Scheduled sale ($552k) by Chief Technology Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $8.82 | 31,278 | $276K | 50.0% |
| 2 | $8.82 | 31,278 | $276K | 50.0% |
| Total | $8.82 avg | 62,556 | $552K | 100% |
| Filing → |
| CADL | SELL | 2025-01-17 | $207K | — | Filing → |
| CADL | SELL | 2025-01-10 | $239K | — | Filing → |
| CADL | SELL | 2024-12-03 | $186K | — | Filing → |